1[1]Kastan MB.Drug sensitivity in cancer [ J ].Bio chimica.Acta,1999,1424:37-42.
2[2]Dean M,Allikets R.Evolution of ATP-binding cassette transportergene[J].CurrOpionGenet,1995,5:779-785.
3[3]Keisuke Miyake,Lyn Mickley.Molecular cloning of cDNA which are highly overexpres-sed in Mitoxantron resistant cells:demonstration of homology to ABC transport genes [ J ].Cancer Research,1999,59 (1),8-13.
4[4]Nitiss J L,Beck W T.Antitopoisomerase drug action and resistance[ J ].Eur.J.Cancer,1996,32A:3075-3081.
5[5]Irene Wessel,Peter B Jense,Jaeob Falk.Loss of amino acids 1490Lys-Ser-Lys 1492 in the COOH-terminal region of topoisome rase Ⅱ in human small lung cancer cells selected for resistance to Etoposide results in an extran-uclear enzyme location [J ].Cancer Research,1997,57:4451-4454.
6[6]Vasey PA,Kaye SB.Combined inhibition of topoisomerase Ⅱ and topoisomerase Ⅰ-is this a worthwhile/feasible strategy [ J ]? British Journal of Cancer,1997,76(11):1395-1397.
7[7]Fink D and Nebe1.S.Loss of DNA mismatch repair due to knockout of Msh2 or Pms2 results in resistance to Cisplatin [J ].Int.J.Oncol,1997,11:539-542.
8[8]Henkels.KM,and Turchi.JJ.Induction of Apoptosis in cisplatin sensitive and resistant human ovarian cancer cell lines [ J ].Cancer Research,1997,57:4488 ～ 4492.
9[9]Karen M.Henkels and John J Turchi.Cisplatin induced apoptosis produceeds by Caspase-3-dependent and independent pathways in Cisplatin resistant and sensitive human ovarian cancer cell lines[J].Cancer Research,1999,59:3077-3083.
10[10]Sarah L,blair,Paul Heerdt,et al.Glutathione metabolism in patients with Non Small cell lung cancers[J].Cancer Research,1997,57:152-155.
